MEDIC — Medicon Hellas SA Cashflow Statement
0.000.00%
- €9.15m
- €14.17m
- €20.77m
- 67
- 98
- 24
- 72
Annual cashflow statement for Medicon Hellas SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 3.6 | 1.53 | 1.45 | 4.78 | 3.66 |
Depreciation | |||||
Non-Cash Items | -1.2 | -0.346 | 0.256 | 0.634 | -0.545 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.164 | -0.739 | -0.044 | -2.31 | -3.49 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 3.19 | 1.62 | 3.07 | 4.79 | 1.25 |
Capital Expenditures | -0.599 | -1.89 | -0.735 | -0.554 | -0.408 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 3.95 | 0.344 | 0.239 | 0.239 | 0.193 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 3.35 | -1.54 | -0.495 | -0.316 | -0.215 |
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -4.74 | -0.228 | -1.45 | -1.32 | -1.18 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.8 | -0.151 | 1.13 | 3.16 | -0.148 |